I recently joined POLITICO’s 2024 Health Care Summit for a panel discussion alongside Joanne Pike, CEO of the Alzheimer’s Association and Traylor Rains, State Medicaid Director of the Oklahoma Health Care Authority. We discussed the importance of putting patients first, examined policies that impact patients and shared ideas about what can be done to lower health care costs across the system.
Here are three highlights from the conversation:
1. The government price-setting policies outlined in the Inflation Reduction Act pose a significant threat to the continued development of small molecule mediciness.
2. The unchecked power held by middlemen known as pharmacy benefit managers (PBMs) within the health care system threatens patient access and affordability.
3. Using medicines to prevent disease can lower costs for patients and the health care system.
Read more about how we can increase access to medicines and improve affordability here.
Lori M. Reilly, Esq.
Lori M. Reilly is chief operating officer at PhRMA, providing executive level management, leadership and strategic direction for the organization. In this role, Reilly oversees PhRMA’s advocacy activities, including its federal, state and international government affairs and alliance development work. Reilly provides strategic leadership and works across PhRMA to develop and advocate for practical policy solutions that will lower costs for patients.
Reilly, named by the Washingtonian as one of the 250 most influential people in D.C., has a long record of working with members of Congress on a bipartisan basis and collaborating with stakeholders across the health care industry. Reilly is a frequent presenter on industry-related issues, including testifying before Congress on multiple occasions.
Reilly has over two decades of experience at PhRMA; prior to her current role, Reilly was the executive vice president of policy, research and membership at PhRMA, leading the development and implementation of legislative, regulatory and political strategies to advance policies that encourage patient access and medical innovation. She has also served as counsel at the U.S. House of Representatives Committee on Commerce and was Counsel to a member of the House Ways and Means Committee.
Reilly received a B.A. in political science from the University of Nebraska-Lincoln where she graduated with honors, and a J.D. from the University of Nebraska College of Law. She currently resides in Alexandria, Virginia with her husband and their four children.
Lori Reilly
https://www.linkedin.com/in/lorireillyphrma/
Chief Operating Officer
What AARP isn’t telling seniors about MFN
Policymakers should improve patient access and reject price controls
CMS proposal could discourage patient-centered innovation
Insurers blame GLP-1s for rising costs. The data tells a different story.
3 Takeaways from POLITICO’s Health Care Summit
Access
Drug Cost
Government Price Setting
PBMs/Insurance
3 Takeaways from POLITICO’s Health Care Summit
3 Takeaways from POLITICO’s Health Care Summit